Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
From MaRDI portal
Publication:4350021
DOI10.2307/2533109zbMATH Open0874.62137OpenAlexW2096498044WikidataQ73331816 ScholiaQ73331816MaRDI QIDQ4350021FDOQ4350021
Authors: Huub Straatman, Petronella G. M. Peer, André L. M. Verbeek 
Publication date: 9 November 1997
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2533109
Recommendations
- Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
- A review of estimation of key parameters and lead time in cancer screening
- Bayesian Inference for the Lead Time in Periodic Cancer Screening
- How well can screening sensitivity and sojourn time be estimated
- Computer simulation of randomized cancer screening trials to compare methods of estimating lead time and benefit time
Cited In (19)
- An age dependent stochastic model of periodic screening: Length bias at a prevalence screen
- Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases
- Estimating the Cumulative Risk of a False-Positive Test in a Repeated Screening Program
- The effect on survival of early detection of breast cancer in South Australia
- Early detection of disease and scheduling of screening examinations
- MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening
- Estimating distribution of the age of onset of detectable asymptomatic cancer
- Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding
- The Natural History of Lung Cancer in a Periodically Screened Population
- Bayesian assessment of times to diagnosis in breast cancer screening
- Evaluating the Age to Begin Periodic Breast Cancer Screening Using Data from a Few Regularly Scheduled Screenings
- Title not available (Why is that?)
- A Note on the Sensitivities of Self-reporting and Screen Detection of Primary Breast Tumours
- Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution
- Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends
- Nonparametric Estimation of Asymptomatic Duration from a Randomized Prospective Cancer Screening Trial
- A Stochastic Model for Calibrating the Survival Benefit of Screen-Detected Cancers
- Significance Tests for Cancer Screening Trials
- Bayesian Inference for the Lead Time in Periodic Cancer Screening
This page was built for publication: Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4350021)
